The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda presents an urgent public health and development challenge for the Great Lakes region. Although smaller so far than the 2014-2016 West Africa Ebola epidemic, history shows how quickly localised outbreaks can escalate when containment is delayed, and health systems are strained.

The immediate policy priority is containment. Failure to control transmission would not only increase mortality but also impose high economic costs through reduced productivity, heightened fiscal burdens and disruptions to trade, investment and development.

As of 7 July, the DRC had reported 1 759 confirmed cases and 600 confirmed Ebolarelated deaths, while Uganda reported 20 confirmed cases and two deaths.

Mortality figures should be interpreted cautiously due to possible under-reporting in remote areas.

No confirmed cases have been reported in neighbouring Rwanda or Burundi. Both countries have, nevertheless, heightened surveillance and preparedness given the extended connections with eastern DRC, especially through the Goma-Rubavu border crossing.

Ebola outbreaks can disrupt healthcare services and weaken health systems’ capacity. As resources are redirected towards emergency responses, the handling of other communicable diseases may suffer, leading to higher overall incidence and mortality rates. This can reverse hard-won gains and strain already struggling health systems, underscoring the importance of swift containment.

In June, the Institute for Security Studies African Futures and Innovation (AFI) programme modelled the impact of a ‘Containment’ scenario against the ‘Current
Path’ (business-as-usual) forecast. The International Futures modelling platform’s ‘other communicable diseases’ category includes Ebola and was used to model the associated effect.

AFI analysis indicates that on the Current Path, fatalities could reach 3,360 in the DRC and 520 in Uganda by the end of 2026, compared to 490 in DRC and 30 in
Uganda under the Containment forecast. (Actual Ebola deaths are already higher than the Containment forecast, indicating the gravity of the situation.) The outcome may worsen in 2027, rising to about 4,340 additional deaths in the DRC and 750 in Uganda.

These figures are well below the 2014-2016 West Africa Ebola epidemic, which resulted in about 11,325 deaths, but they underscore the risks of delayed
intervention.

Containing the outbreak will require a significant increase in public health expenditure to enable better disease surveillance, laboratory testing, treatment
facilities, community outreach and emergency response systems. These interventions would not only limit transmission but restore public confidence and maintain economic activity.

AFI’s Containment scenario indicates that government health expenditure in 2026 would need to rise to at least US$1.82 billion in the DRC and US$1.17 billion in Uganda. This represents an increase of over US$540 million above the Current Path forecast in the DRC and US$170 million in Uganda. Taken together, at least US$710 million in additional health financing would be required to effectively contain the outbreak.

The benefits of early intervention would be substantial in terms of lives saved. Rapid containment is also significantly less costly than responding to a larger, more entrenched epidemic later.

The estimated financing requirement is broadly consistent with the US$518 million emergency appeal the United Nations and humanitarian partners launched on 5 June. Several governments and development partners have already pledged support, but crisis financing is often reactive and temporary.

The current outbreak highlights the need for more systematic investment in epidemic preparedness, surveillance systems, laboratory infrastructure, community
health workers and rapid-response capacity.

However, additional health spending should not come at the expense of other development priorities. African governments are often forced to divert resources
from education, social protection, food security and infrastructure during crises. This risks undermining long-term development outcomes and shifting the burden of the emergency onto vulnerable populations.

The challenge is not only to mobilise emergency financing, but to secure additional, flexible resources that allow governments to respond without compromising broader development objectives.

Ebola can also discourage market participation due to uncertainty and fear of infection. Border restrictions, reduced travel and disruptions to transport networks constrain trade, services and agricultural activity. These effects are particularly significant in the Great Lakes region, where communities rely on cross-border economic and social ties. If containment is further delayed, the region could face rising communicable disease fatalities alongside slower economic growth.

Often, economic activity does not disappear entirely but shifts into informal, unmonitored channels as households try to preserve their incomes and livelihoods.

As informality increases, governments collect less revenue from customs duties, corporate taxes and other domestic sources.

AFI modelling shows that in 2026, the DRC and Uganda could lose around US$70 million and US$60 million in government revenue, respectively, due to reduced formal economic activity, increased informality and the fiscal strain of financing the outbreak response. Both governments are already under pressure to finance emergency health interventions while sustaining critical development spending.

Four key policy implications emerge from these findings.

First, early containment would be far less costly than the burden of uncontrolled escalation. Rapid intervention saves lives, reduces economic disruption and lowers long-term fiscal costs. Second, emergency health financing must be mobilised quickly and should be additional to existing development resources.

Third, responses should protect livelihoods and formal economic activity wherever possible, particularly in border communities relying on trade and mobility.

Finally, the outbreak reinforces the importance of investing in resilient health systems before crises occur. Strong surveillance networks, laboratory systems, community health workers and cross-border preparedness mechanisms are the most effective safeguards against future epidemics.

The African Development Bank and other development partners can mobilise rapidresponse financing, support health-system resilience and strengthen regional preparedness. Epidemic preparedness must be recognised not just as a health priority, but as a development, fiscal stability and regional resilience imperative.

Marvellous Ngundu is a Research Consultant, Blessing Chipanda is a Senior Research Consultant, and Jakkie Cilliers is Head of African Futures and Innovation at the Institute for Security Studies (ISS) Pretoria.

(This article was first published by ISS Today, a Premium Times syndication partner. We have their permission to republish).

The Nigeria Centre for Disease Control and Prevention (NCDC) has said the country’s Lassa fever outbreak has become deadlier this year, with 221 deaths recorded and the case fatality rate rising to 24 per cent, compared with 18.7 per cent during the corresponding period in 2025.

The agency disclosed this in its Lassa fever situation report for epidemiological week 26, released on Friday.

The report also showed that confirmed infections increased during the week, with 31 new cases recorded, up from 22 in the previous reporting week.

A total of 23 states have recorded at least one confirmed case across 111 local government areas this year, highlighting the continued spread of the disease across the country.

Five states account for most infections

The NCDC reported that 85 per cent of all confirmed cases originated from Ondo, Bauchi, Taraba, Edo and Benue states, while the remaining 15 per cent were reported elsewhere.

Ondo accounted for the largest share of confirmed infections at 30 per cent, followed by Bauchi (26 per cent), Taraba (14 per cent), Edo (nine per cent) and Benue (six per cent).

People aged 21 to 30 years remained the most affected group, although confirmed cases ranged from one to 93 years.

The male-to-female ratio among confirmed cases stood at 1:0.9, indicating nearly equal infection rates between men and women.

Why deaths remain high

The NCDC attributed the elevated fatality rate to several persistent challenges, including late presentation of cases, poor health-seeking behaviour driven by the high cost of treatment, inadequate environmental sanitation in high-burden communities, low public awareness, and infections among healthcare workers.

The agency disclosed that one healthcare worker was infected during week 26.

Response efforts intensified

To contain the outbreak, the NCDC said the National Lassa Fever multi-partner, multi-sectoral Incident Management System remains activated to coordinate surveillance, case management, risk communication and response activities nationwide.

During the reporting week, the agency and its partners supported case management training for healthcare workers, active case search and contact tracing, infection prevention and control (IPC) training, community engagement activities, distribution of personal protective equipment, laboratory testing, and high-level field missions to affected states.

The NCDC urged state governments to sustain year-round community engagement on Lassa fever prevention, while healthcare workers were advised to maintain a high index of suspicion for the disease, initiate timely referral and treatment, and adhere strictly to infection prevention and control procedures.

READ ALSO: NCDC updates Lassa fever death rate to 19.3% as outbreak reaches 23 states

Lassa fever

Lassa fever is an acute viral haemorrhagic illness caused by the Lassa virus, which is transmitted to humans primarily through contact with food or household items contaminated by the urine or faeces of infected rats.

It can also spread from person to person through contact with bodily fluids.

The disease often begins with fever, weakness, and headache, and may progress to more severe symptoms such as bleeding, difficulty breathing, swelling, and organ failure.

Early diagnosis and prompt treatment with Ribavirin are critical for improving survival.